Immunodeficiency Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Immunodeficiency stocks.

Immunodeficiency Stocks Recent News

Date Stock Title
Jul 1 HOOK HOOKIPA Pharma Announces First Person Dosed in Phase 1b Clinical Trial of HB-500 for the Treatment of HIV
Jul 1 BMY What the Options Market Tells Us About Bristol-Myers Squibb
Jul 1 BMY Bristol-Myers Squibb to Pay $2.7 Million to Settle Potential Anti-Competition Case, Israeli Agency Says
Jul 1 GILD Gilead Benefit Helps Employees Navigate Cancer Care
Jul 1 INO Inovio Pharmaceuticals added to Russell 2000 index effective July 1
Jul 1 BMY Bristol Myers to pay $2.7 million to settle Israel anti-competition charges
Jul 1 INO INOVIO Added to Russell 2000® Index Effective July 1, 2024
Jul 1 BMY Eisai and Bristol Myers cancel cancer ADC deal
Jul 1 GILD Should You Hold Gilead Sciences (GILD)?
Jul 1 GILD 3 Magnificent Stocks Retirees Can Buy and Hold Forever
Jun 28 BMY Bristol-Myers Squibb: Time To Double Down
Jun 28 AEMD Aethlon Medical, Inc. (NASDAQ:AEMD) Q4 2024 Earnings Call Transcript
Jun 27 AEMD Aethlon Medical, Inc. (AEMD) Q4 2024 Earnings Call Transcript
Jun 27 AEMD Aethlon Medical GAAP EPS of -$4.86 beats by $0.33
Jun 27 AEMD Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update
Jun 27 BMY Novo Nordisk Buys 2seventy's Hemophilia A Program, Divestiture Supports Exclusive Focus On Abecma
Jun 27 GOVX GeoVax Partners with Allucent to Conduct Phase 2b Clinical Study of Next-Generation COVID-19 Vaccine Candidate with Funding from BARDA
Jun 26 AEMD Aethlon Medical FY 2024 Earnings Preview
Jun 26 GILD Recent uptick might appease Gilead Sciences, Inc. (NASDAQ:GILD) institutional owners after losing 4.6% over the past year
Jun 26 VIR Vir Biotechnology Receives FDA IND Clearance and Fast Track Designation for Tobevibart and Elebsiran for the Treatment of Chronic Hepatitis Delta Infection
Immunodeficiency

Immunodeficiency, also known as immunocompromisation, is a state in which the immune system's ability to fight infectious diseases and cancer is compromised or entirely absent. Most cases are acquired ("secondary") due to extrinsic factors that affect the patient's immune system. Examples of these extrinsic factors include HIV infection and environmental factors, such as nutrition.
Immunocompromisation may also be due to genetic diseases/flaws. An example here is SCID.
In clinical settings, immunosuppression by some drugs, such as steroids, can either be an adverse effect or the intended purpose of the treatment. Examples of such use is in organ transplant surgery as an anti-rejection measure and in patients suffering from an overactive immune system, as in autoimmune diseases. Some people are born with intrinsic defects in their immune system, or primary immunodeficiency.A person who has an immunodeficiency of any kind is said to be immunocompromised. An immunocompromised individual may particularly be vulnerable to opportunistic infections, in addition to normal infections that could affect anyone. It also decreases cancer immunosurveillance, in which the immune system scans the body's cells and kills neoplastic ones.

Browse All Tags